IL-6: Supports cancer cell proliferation and survival; also promotes osteoclast differentiation, which leads to bone resorption (126).IL-8: Enhances the invasiveness and migration of breast cancer cells (127).IL-11: Contributes to osteoclastogenesis and bone resorption (128). This evidence concerns the gene CXCL8 and breast carcinoma.